首页 | 本学科首页   官方微博 | 高级检索  
检索        

脑小血管病患者血清 CTRP1和同型半胱氨酸水平对血管性轻度认知障碍预测价值的研究
引用本文:张春丽a,张 颖b,李 璐c,冉 芳a,杨 静b,吕天薇d.脑小血管病患者血清 CTRP1和同型半胱氨酸水平对血管性轻度认知障碍预测价值的研究[J].现代检验医学杂志,2022,0(1):182-185.
作者姓名:张春丽a  张 颖b  李 璐c  冉 芳a  杨 静b  吕天薇d
作者单位:(沧州市人民医院a. 神经内科;b. 康复医学科;c. 检验科;d. 科教科,河北沧州 061000)
摘    要:目的 探讨血补体 C1q/肿瘤坏死因子相关蛋白 1(CTRP1),血同型半胱氨酸( Homocysteine,Hcy)预测脑小血管疾病( cerebral small vessel disease,CSVD)患者血管性轻度认知障碍( vascular mild cognitive impairment,VaMCI)的临床价值。方法 选取 2015年 12月~ 2019年 12月沧州市人民医院收治的 98例 CSVD患者,采用蒙特利尔评估表(Montreal cognitive assessment,MoCA)对其进行认知能力检查,分为 VaMCI组(n=56)和认知正常组( n=42)。分别采取 Logistic回归分析以及 Pearson相关性分析 CTRP1、血同型半胱氨酸与 VaMCI之间的相关性。结果 VaMCI组 Hcy,CTRP1以及 UA水平均高于认知正常组 (Hcy:22.02±3.74μmol/L vs 18.43±3.52μmol/L,CTRP1:162.54±14.85ng/ ml vs 135.26±13.41ng/ml,UA:360.27±23.28μmol/L vs 320.55±20.23μmol/L),差异均有统计学意义( t=4.822,9.377,

关 键 词:脑血管病变  轻度认知障碍  同型半胱氨酸  补体  C1q/肿瘤坏死因子相关蛋白  1

Study on the Predictive Value of Serum CTRP1 and Homocysteine Levels in Patients with Cerebral Small Vessel Diseases inVascular Mild Cognitive Impairment
ZHANG Chun-lia,ZHANG Yinb,LI Luc,RAN Fanga,YANG Jingb,L? Tian-weid.Study on the Predictive Value of Serum CTRP1 and Homocysteine Levels in Patients with Cerebral Small Vessel Diseases inVascular Mild Cognitive Impairment[J].Journal of Modern Laboratory Medicine,2022,0(1):182-185.
Authors:ZHANG Chun-lia  ZHANG Yinb  LI Luc  RAN Fanga  YANG Jingb  L? Tian-weid
Institution:(a.Department of Neurology;b. Department of Rehabilitation Medicine;c. Department of Clinical Laboratory;d. Department of Science and Education, Cangzhou People’s Hospital, Hebei Cangzhou 061000, China)
Abstract:Objective To investigate the clinical value of vascular mild cognition in patients with cerebral small vessel disease(CSVD) by blood complement C1q / tumor necrosis factor related protein 1 (CTRP1) and blood homocysteine (Hcy) in predictingvascular mild cognitive impairment (VaMCI) in patients with cerebral small blood vessels. Methods From December 2015 toDecember 2019, 98 CSVD patients admitted to Cangzhou People’s Hospital were selected as the research subjects, and theircognitive abilities were examined using the Montreal cognitive assessment (MoCA). There were 56 cases in VaMCI group, 42cases in normal cognitive group and 60 cases in healthy control group. Logistic regression analysis and Pearson correlationanalysis were used to analyze the correlation between CTRP1, blood homocysteine and VaMCI. Results The levels of Hcy,CTRP1 and UA in the VaMCI group were higher than those in the cognition normal group (Hcy:22.02±3.74μmol/L vs18.43±3.52μmol/L, CTRP1:162.54±14.85ng/ml vs 135.26±13.41ng/ml, UA:360.27±23.28μmol/L vs 320.55±20.23μmol/L), the differences were statistically significant(t=4.822,9.377,8.833, P<0.001). Logistic regression analysis results showedthat Hcy, CTRP1 and UA were all risk factors for VaMCI in CSVD patients (Hcy:OR=2.782, 95%CI:1.515~5.107,P=0.001;CTRP1:OR=3.401, 95%CI:1.729~6.687,P=0.000; UA:OR=2.335, 95%CI:1.325~4.114, P=0.003); and that in VaMCIgroup, Hcy and CTRP1 were negatively correlated with MoCA total score (r = -0.415, -0.467, P <0.05). In the VaMCI group,Hcy and CTRP1 levels were negatively correlated with sub-items such as memory, language, visual space, and executive ability (r= -0.402, -0.436;- 0.365,- 0.379; -0.512,-0.536, all P <0.05). Conclusion CSVD patients with VaMCI serum CTRP1 andHcy expression levels were significantly increased, and both are independent risk factors for VaMCI in CSVD patients, both ofwhich are significantly related to the patient’s MoCA total score, memory, language, visual space and executive ability. Earlydetection of CSVD serum CTRP1 and Hcy levels are of great significance for preventing cognitive dysfunction.
Keywords:
点击此处可从《现代检验医学杂志》浏览原始摘要信息
点击此处可从《现代检验医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号